U.S. FDA Approves Gilead’s StribildTM, a Complete Once-Daily Single Tablet Regimen for Treatment-Naïve Adults with HIV …

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration has approved StribildTM , a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Powered by WPeMatico